FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Alzheimer's Disease
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
Alzheimer’s Drug Slows Disease Progression in Trial
The pharmaceutical companies said their drug lecanemab reduced cognitive and functional decline by 27%, compared with a placebo, over 18...
FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns
The U.S. Food and Drug Administration approved the first new Alzheimer’s drug in decades over the objection of agency statisticians...
Pill-Dispensing Tech Makes the Medicine Go Down…With Human Help, That Is
When Stephanie Luehrs’s father began losing track of what day it was, she knew his pre-filled pill packs were no...
Lilly Alzheimer’s Drug Shows Modest Benefit in Clinical Trial
An Eli Lilly LLY 1.40% & Co. experimental drug modestly slowed the cognitive and functional decline of early-stage Alzheimer’s patients...
